Physician

Patrick Joseph Glynn, M.D.

According to 2025 Medicare claims, Patrick Glynn, M.D. (NPI: 1508050857) practices neurology in the Slidell-Mandeville-Covington, LA market, with the plurality of this provider's patient population coming from St. Tammany, LA. This provider's primary affiliated billing organization is PARADIGM HEALTH SYSTEM (NPI: 1780929604; TIN: 461045337) and primary practice location at 70458-2009.

Glynn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 286 traditional Medicare patients, billed 12,675 HCPCS/CPT codes, and received $131,259 in Medicare payments. The top billing code was 99483 (Assessment of and care planning for patient with impaired thought processing, typically 60 minutes). Part D data shows 2,944 prescription claims across 352 beneficiaries totaling $1,651,194 in drug costs, led by Gamunex-C (Immune Globul G/Gly/Iga Avg 46). 2023 DME data shows 13 claims. Open Payments data shows 189 records totaling $3,322. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $89,012 to $131,259. Similarly, Part D prescription costs have risen steadily, from $157,228 to $1,651,194. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $10,854 to $1,473.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	332	3,639	$89,012
2016	337	3,863	$85,816
2017	297	5,068	$101,610
2018	268	4,758	$83,014
2019	278	5,662	$91,475
2020	232	5,393	$76,979
2021	251	7,020	$99,085
2022	265	10,325	$119,165
2023	297	9,795	$123,855
2024	286	12,675	$131,259

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	213	1,508	$157,228
2016	241	1,687	$311,620
2017	259	1,979	$830,598
2018	259	1,919	$860,749
2019	254	1,820	$931,669
2020	246	1,813	$962,285
2021	286	2,155	$1,094,919
2022	349	2,580	$1,233,463
2023	358	2,624	$1,390,603
2024	352	2,944	$1,651,194

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	71	$4,981
2017	N/R	N/R	N/R
2018	N/R	14	$237
2019	N/R	N/R	N/R
2020	N/R	12	$433
2021	N/R	17	$569
2022	N/R	N/R	N/R
2023	N/R	13	$343
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99483	Assessment of and care planning for patient with impaired thought processing, typically 60 minutes	39	44	$187
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	90	90	$141
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	79	101	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	157	233	$77
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	151	207	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	72	2,244	$407,631
Gammaked	Immune Globul G/Gly/Iga Avg 46	15	267	$324,573
Nuplazid	Pimavanserin Tartrate	36	1,080	$170,840
Aimovig Autoinjector	Erenumab-Aooe	104	3,322	$83,155
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	16	448	$81,473

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	189	$3,322	ACADIA Pharmaceuticals Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Patrick Joseph Glynn, M.D.?

Tedicare shows public-source Medicare data for Patrick Joseph Glynn, M.D. (NPI 1508050857), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Patrick Joseph Glynn, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Patrick Joseph Glynn, M.D.?

Patrick Joseph Glynn, M.D. is linked to PARADIGM HEALTH SYSTEM (billing NPI 1780929604) in the available physician profile data.

Does Patrick Joseph Glynn, M.D. have Open Payments data?

Patrick Joseph Glynn, M.D. has 189 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.